Literature DB >> 7646989

Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis.

M Mitterer1, N Pescosta, F Fend, C Larcher, N Prang, F Schwarzmann, P Coser, H P Huemer.   

Abstract

Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare haematological disorder. It is characterized by activated and morphologically atypical B lymphocytes and polyclonal IgM production and has been associated with female sex, cigarette smoking, and HLA-DR7 expression. We report a case of PPBL with intermitting symptoms compatible with a chronic fatigue syndrome, recurrent erythema nodosum and multiforme. Serological findings suggested a chronic active Epstein-Barr virus (EBV) infection. Messenger RNA of EBV immediate early gene transactivation BZLF1 was detected in peripheral blood lymphocytes by reverse transcriptase PCR indicating a persistent replication of the virus. Over 2 years of observation we detected varying numbers of atypical lymphocytes. These cells hybridized with a probe specific for the EBV internal repeat region (BamHI W) which indicates a productive infection. Of interest, no reaction was observed with a probe specific for the latency-associated small RNAs (EBERs). The immunological phenotype of the polyclonal B cells was similar to B-cell lines immortalized by EBV in vitro, expressing a number of activation molecules (CD23, CD25, CD54) and the bcl-2 protein. In summary, our findings suggest that persistent EBV replication might be crucial in the development of lymphoproliferative disorders such as PPBL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646989     DOI: 10.1111/j.1365-2141.1995.tb05579.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication.

Authors:  N Greifenegger; M Jäger; L A Kunz-Schughart; H Wolf; F Schwarzmann
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

2.  Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL).

Authors:  Xavier Troussard; Edouard Cornet; Jean-François Lesesve; Carine Kourel; Hossein Mossafa
Journal:  Onco Targets Ther       Date:  2008-10-01       Impact factor: 4.147

3.  DNA methylation modifications associated with chronic fatigue syndrome.

Authors:  Wilfred C de Vega; Suzanne D Vernon; Patrick O McGowan
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

4.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.